Navigation Links
First Potential Lupus-Specific Treatment in Sight
Date:7/19/2009

y approve BENLYSTA, it would become the first drug successfully developed to specifically treat lupus since the disease was discovered more than a century ago.

"Lupus is a complex disease and not every therapy will be appropriate for all patients. Each person with lupus is unique and it is likely that successful management of lupus will require a number of therapies, perhaps used in combination with each other. The LFA and its Medical-Scientific Advisory Council urge the federal government and industry to greatly step up their research efforts on lupus so that physicians have a complete arsenal of therapies at their disposal to provide the individualized treatment that lupus requires.

"We are grateful to Human Genome Sciences and GlaxoSmithKline for their pioneering efforts to develop a new, safe, effective and tolerable treatment for lupus, to the physicians who have passionately committed to researching this disease, to the companies who continue to invest in finding new treatments, and to the thousands of people with lupus who have volunteered and participated in clinical studies over the years so discoveries such as this one could be possible.

"Meanwhile, the LFA will continue to implement its initiative entitled, A New 21(st) Century Approach to Lupus Healthcare, to ensure the ongoing advancement of the science and medicine of lupus to meet the multi-dimensional needs of people with lupus."

View a video of Sandra Raymond's remarks on the LFA website.

About Lupus

Lupus is an acute and chronic autoimmune disease in which the immune system is unbalanced, causing inflammation and tissue damage to virtually any organ in the body. Its health effects include heart attacks, strokes, seizures, miscarriages, and organ failure. Ninet
'/>"/>

SOURCE Lupus Foundation of America
Copyright©2009 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2 3

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...BOSTON, Nov. 20 The United States ...earlier District Court ruling yesterday, approving...e Price (AWP) pharmaceutical litigation against As...tp://www.newscom.com/cgi-bin/prnh/20080317/AQM144L...warded consumers who purchased the pharmaceutical ...
(Date:11/20/2009)...NWOOD, Ill., Nov. 20 /PRNewswire-FirstCall/ -- ...esults for the fiscal fourth quarter and full year...,, The company will host a conference call for ...m. Eastern Time. Investors may access the live cal...s and Canada), or 480-629-9835 (international call...
(Date:11/20/2009)..., NEW YORK, Nov. 20 Reportlinker.c...available in its catalogue. ,, Global Self Mon...option to Drive Growth ,, http://www.reportl...ucose-Market-(SMBG )-Increasing-Adoption-to-Drive-...r&utm_campaign=prnewswire ,, Description ...
Breaking Medicine Technology:U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 3Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 4Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 5Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 6Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 7Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 8Common plants can eliminate indoor air pollutants 60694 1Common plants can eliminate indoor air pollutants 60694 2Emerging infectious diseases call for One Health summit Nov 17 60691 1Cholesterol and Cancer 3A Answers and Some New Questions 60688 1Cholesterol and Cancer 3A Answers and Some New Questions 60688 2Cholesterol and Cancer 3A Answers and Some New Questions 60688 3Cholesterol and Cancer 3A Answers and Some New Questions 60688 4Cholesterol and Cancer 3A Answers and Some New Questions 60688 5
...ell Therapeutics (CTI) (NASDAQ and MTA: CTIC) toda...ollaborative agreement with IDIS to manage its inv...sis in Europe. Pixantrone will be supplied by IDI... individual patients with relapsing aggressive non...be initiated by second quarter of 2009. , , "Und...
...9 Sequoia Pharmaceuticals presented,positive resu...nteers and,preclinical studies on SPI-452, a novel...ntiviral activity. Pharmacokinetic enhancers incre...inhibition of cytochrome P450 (CYP)-mediated,drug ...o improved efficacy,reduced pill burden, and reduc...
Other Medicine Technology:Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone 2Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone 3Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone 4Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone 5Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer 2Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer 3Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer 4Sequoia Pharmaceuticals Presents Proof of Clinical Concept of SPI-452, a Novel Pharmacokinetic Enhancer 5
(Date:11/22/2009)... innovative healthcare benefit solutions company, ... a recapitalization with Silver Point Capital, L.P...oint Capital, L.P. is a private investment firm ba...ion allows the Company to continue its growth and ... (PRWEB) November 22, 2009 -- HealthSm...
(Date:11/22/2009)...-USNewswire/ -- Congressman Chaka Fattah (D-PA) is...s Senate,s vote tonight to proceed to debate on Af...Arlen Specter and Bob Casey deserve the thanks of ...stand-up, critical votes in the Senate tonight adv...h Care Reform legislation to full debate. The Pres...
(Date:11/21/2009)...n unprecedented expansion of federally-funded abor...reserving and protecting human life? If the bill i...est ,, WASHINGTON, Nov. 21 /PRNewswire-USNews...t and CEO Dr. Charmaine Yoest responded to tonight...tatement: ,, "This was a pro-abortion vote ton...
(Date:11/21/2009)...ovisions of Legislation, Continues Push for Progre... Nov. 21 With the U.S...fordable Health Care for America Act (H.R. 3962), ...n forward, Congress has taken decisive steps to fi...AARP hosted an educational forum to discuss the pr...
(Date:11/21/2009)...cal apparel company launches men,s lab coats at Me...n Clemente, Calif. (PRWEB) November 21, 2009 -- Me..., today announced the launch of its men,s lab coat...international trade fair for the medical industry ...its men,s collection with three varying lab coat s...
Breaking Medicine News(10 mins):Health News:HealthSmart Completes Recapitalization to Support Continued Growth, Daniel D. Crowley Named Chairman 2Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3
...ounced that the first implant of its proprietary m...y performed by Dr. Moeen Saleem, Midwest Heart Spe...pital in Naperville, Illinois. The device is used ...al site. Dr. Maria Rosa Costanzo, Midwest Heart Sp...
...e in the UK has fallen to its lowest levels since ...report of the National Suicide Prevention Strategy...young people who are committing suicides as well a...nd elsewhere. At a personal level, suicide is a te...
... to carry out tests to determine the efficacy of s...dia reported on Sunday. The program designed to st...the Department of Medical Sciences, Mahidol Univer...idelines on this new technology and was unaware of...
...ensioners and the ageing millions in the country i...sing acquired //skills to provide a helping hand t...rden on anyone. I want a smile on everyone's face ...the cause of senior citizens. At 81, the for...
...ors in Andhra Pradesh have decided to partially ca... cases on Saturday. //Earlier in the day, about 4,... Raj Bhavan and blocked the road in front of the g...government's decision to hike the in-house quota f...
...nc., based in Coral Springs, Florida, have decided...ringe 30g 1/2cc due to possible // contamination o...The products if not recalled, may degrade the insu...rts foodconsumer.org. Consumers, who use Ulti...
Other Medicine News:Health News:Change In Mental Makeup Could Prove Beneficial For Elders 2Health News:Change In Mental Makeup Could Prove Beneficial For Elders 3
3.5v Streak Retinoscope Set with Rechargeable Handle and Hard Case
3.5v Streak Retinoscope Set with Rechargeable Handle and Soft Case
3.5v Streak Retinoscope Set with Convertible Handle and Hard Case
3.5v Spot Retinoscope Set with Rechargeable Handle and Soft Case
Medicine Products: